Cell Free DNA

New UW Medicine-BBI Study Identifies Association Between Severity of Preeclampsia and Cell-Free DNA

July 28, 2021 | by BBI Communications

A new scientific study led by Brotman Baty Institute members offers insights into pregnant women with preeclampsia and the association between the severity of the condition and high-circulating cell-free DNA.

Read More

Test reliably detects tumor mutations in blood of patients with advanced prostate cancer

June 10, 2019 | by By Michael McCarthy

Sequencing cell-free DNA found in blood plasma could provide patients with advanced disease an alternative to biopsy

Read More

BBI Cell-free DNA Working Group Assesses First Year of Progress

June 26, 2019 | by Michael McCathy, MD

The Brotman Baty Institute for Precision Medicine (BBI) launched its cell-free DNA (cfDNA) working group in 2018, awarding grants for more than a dozen pilot studies to apply a cfDNA assay developed and validated by BBI to address a wide variety of clinical challenges.

Read More